Search
Upadacitinib
go.drugbank.com/drugs/DB15091ApprovedInvestigationalUpadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis to slow down disease progression. … [A189165] The FDA approved upadacitinib in August 2019 and it is used for the treatment of active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and ankylosing spondylitis
Synonyms: UpadacitinibSalts: Upadacitinib tartrate, Upadacitinib hemihydrateUpadacitinib Drug Metabolism
smpdb.ca/view/SMP0130776MetabolicUpadacitinib passes through the liver and is then excreted from the body mainly through the kidney. … Upadacitinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: UpadacitinibElsubrutinib
go.drugbank.com/drugs/DB18850InvestigationalElsubrutinib is under investigation in clinical trial NCT04451772 (A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants
Severe Atopic Dermatitis
go.drugbank.com/conditions/DBCOND0033062